MedTrace Logo

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

NCT01098630 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 778

Last updated 2018-04-12

No results posted yet for this study

Summary

This clinical trial is studying patient, physician, and nurse factors associated with entry onto clinical trials and finishing treatment in patients with primary or recurrent uterine, endometrial, or cervical cancer. Determining how patients make decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are satisfied with their decision to participate.

Conditions

  • Recurrent Cervical Carcinoma
  • Recurrent Uterine Corpus Carcinoma
  • Recurrent Uterine Corpus Sarcoma
  • Stage I Uterine Corpus Cancer
  • Stage I Uterine Sarcoma
  • Stage IA Cervical Cancer
  • Stage IB Cervical Cancer
  • Stage II Uterine Corpus Cancer
  • Stage II Uterine Sarcoma
  • Stage IIA Cervical Cancer
  • Stage IIB Cervical Cancer
  • Stage III Cervical Cancer
  • Stage III Uterine Corpus Cancer
  • Stage III Uterine Sarcoma
  • Stage IV Uterine Corpus Cancer
  • Stage IV Uterine Sarcoma
  • Stage IVA Cervical Cancer
  • Stage IVB Cervical Cancer

Interventions

OTHER

Medical Chart Review

Patients' medical record information is collected and staff complete the treatment review form

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Gynecologic Oncology Group

    lead NETWORK

Principal Investigators

  • Sandra Brooks · Gynecologic Oncology Group

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-05-31
Completion
2018-01-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01098630 on ClinicalTrials.gov